<DOC>
	<DOCNO>NCT01657890</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics isavuconazole healthy non-elderly elderly male female subject .</brief_summary>
	<brief_title>Study Pharmacokinetics Isavuconazole Healthy Non-Elderly Elderly Male Female Subjects</brief_title>
	<detailed_description>All subject receive single dose isavuconazole Day 1 fasting condition . Subjects confine study center Day -1 Day 4 discharge . Subjects return outpatient visit Days 6 , 8 , 11 , 13 15 .</detailed_description>
	<criteria>Subjects healthy , nonelderly male females 18 45 year healthy , elderly male females 65 year age older The subject body weight least 45 kg body mass index ( BMI ) 18 32 kg/m2 , inclusive The estimate ( calculate ) creatinine clearance must within ageappropriate normal range , abnormal , abnormality clinically significant , determined Investigator Results aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) , total bilirubin must within normal range The Female subject agree sexual abstinence , surgically sterile , postmenopausal ( define least 2 year Screening without menses ) , use medically acceptable double barrier method ( e.g . spermicide diaphragm , spermicide condom ) prevent pregnancy agree continue use method Screening 3 week followup visit end study ; lactate pregnant document negative pregnancy test Screening Day 1 The Male subject agree sexual abstinence , surgically sterile , use medically acceptable method prevent pregnancy agree continue use method Screening 3 week followup visit end study The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probable cardiac cause ) The subject positive result hepatitis C antibody , hepatitis B surface antigen Screening know positive human immunodeficiency virus ( HIV ) The subject know suspect allergy component trial product include azole class compound , history multiple and/or severe allergy drug food ( judge investigator ) , history severe anaphylactic reaction The subject smoker ( use tobacco nicotine containing product ) within 6 month prior Screening The subject , nonelderly , treatment prescription drug complementary alternative medicine within 14 day prior Day 1 , overthecounter medication within 1 week prior Day 1 , exception acetaminophen 2 g/day The subject , elderly , stable concomitant medication ( minor necessary dosing change acceptable ) least 4 week prior study drug administration take medication would interfere evaluation isavuconazole study ( CYP3A4 inducer inhibitor ) The subject recent history ( within last 2 year ) drug alcohol abuse , define investigator , positive drug and/or alcohol screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>isavuconazole</keyword>
	<keyword>BAL8557</keyword>
</DOC>